Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156860669> ?p ?o ?g. }
- W2156860669 endingPage "864" @default.
- W2156860669 startingPage "859" @default.
- W2156860669 abstract "Numerous reports have appeared on lamivudine use for the treatment of hepatitis B virus (HBV) infection after renal transplantation (RT). However, the efficacy and safety of lamivudine after RT remain unclear.The authors evaluated the efficacy and safety of initial lamivudine monotherapy in RT recipients with hepatitis B by performing a systematic review of the literature with a meta-analysis of clinical trials. The primary outcomes were hepatitis B (HB) e antigen (Ag) and HBV-DNA clearance (as measures of efficacy); the secondary outcomes were biochemical response (as measures of efficacy), dropout rate, and lamivudine resistance (as measures of tolerability). The authors used the random effects model of DerSimonian and Laird, and outcomes were analyzed on an intent-to-treat basis.The authors identified 14 clinical trials (184 patients); all of these were prospective cohort studies. The mean overall estimate for HBV-DNA and HBeAg clearance, alanine aminotransferase normalization, and lamivudine resistance was 91% (95% confidence interval [CI], 86%-96%), 27% (95% CI, 16%-39%), 81% (95% CI, 70%-92%), and 18% (95% CI, 10%-37%), respectively. HBeAg seroconversion rate was assessed in four (28%) trials and ranged between 0% and 46%. The P value was greater than 0.05 for our test of study homogeneity. There was no association between rate of patients who were male patients or had cirrhosis, race, age, lamivudine dose, and HBV-DNA or HBeAg clearance. Increased duration of lamivudine therapy was positively associated with frequency of HBeAg loss (r =0.51, P =0.039) and lamivudine resistance (r =0.620, P =0.019). Only 2 (14%) of 14 studies reported a dropout rate greater than 0%.Our meta-analysis showed that the majority of RT recipients with hepatitis B had high virologic and biochemical response with lamivudine. Tolerance to lamivudine was good. However, lamivudine resistance was frequent with prolonged therapy, potentially limiting its long-term efficacy after RT." @default.
- W2156860669 created "2016-06-24" @default.
- W2156860669 creator A5003259966 @default.
- W2156860669 creator A5056355381 @default.
- W2156860669 creator A5085016171 @default.
- W2156860669 creator A5088923226 @default.
- W2156860669 creator A5089277250 @default.
- W2156860669 date "2004-03-27" @default.
- W2156860669 modified "2023-10-09" @default.
- W2156860669 title "Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials" @default.
- W2156860669 cites W1494265273 @default.
- W2156860669 cites W1966987192 @default.
- W2156860669 cites W1968974532 @default.
- W2156860669 cites W1976411156 @default.
- W2156860669 cites W1998783254 @default.
- W2156860669 cites W2010857849 @default.
- W2156860669 cites W2014320909 @default.
- W2156860669 cites W2027226875 @default.
- W2156860669 cites W2037234985 @default.
- W2156860669 cites W2042848792 @default.
- W2156860669 cites W2043210068 @default.
- W2156860669 cites W2065703724 @default.
- W2156860669 cites W2080805631 @default.
- W2156860669 cites W2085152039 @default.
- W2156860669 cites W2090126805 @default.
- W2156860669 cites W2096841420 @default.
- W2156860669 cites W2107328434 @default.
- W2156860669 cites W2107944356 @default.
- W2156860669 cites W2130835730 @default.
- W2156860669 cites W2137544368 @default.
- W2156860669 cites W2138002053 @default.
- W2156860669 cites W2138628280 @default.
- W2156860669 cites W2152641479 @default.
- W2156860669 cites W2162840120 @default.
- W2156860669 cites W2163330829 @default.
- W2156860669 cites W2338794667 @default.
- W2156860669 cites W3152231134 @default.
- W2156860669 cites W4362208329 @default.
- W2156860669 doi "https://doi.org/10.1097/01.tp.0000116448.97841.6d" @default.
- W2156860669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15077027" @default.
- W2156860669 hasPublicationYear "2004" @default.
- W2156860669 type Work @default.
- W2156860669 sameAs 2156860669 @default.
- W2156860669 citedByCount "82" @default.
- W2156860669 countsByYear W21568606692012 @default.
- W2156860669 countsByYear W21568606692013 @default.
- W2156860669 countsByYear W21568606692014 @default.
- W2156860669 countsByYear W21568606692015 @default.
- W2156860669 countsByYear W21568606692016 @default.
- W2156860669 countsByYear W21568606692017 @default.
- W2156860669 countsByYear W21568606692018 @default.
- W2156860669 countsByYear W21568606692019 @default.
- W2156860669 countsByYear W21568606692021 @default.
- W2156860669 countsByYear W21568606692023 @default.
- W2156860669 crossrefType "journal-article" @default.
- W2156860669 hasAuthorship W2156860669A5003259966 @default.
- W2156860669 hasAuthorship W2156860669A5056355381 @default.
- W2156860669 hasAuthorship W2156860669A5085016171 @default.
- W2156860669 hasAuthorship W2156860669A5088923226 @default.
- W2156860669 hasAuthorship W2156860669A5089277250 @default.
- W2156860669 hasBestOaLocation W21568606691 @default.
- W2156860669 hasConcept C126322002 @default.
- W2156860669 hasConcept C197934379 @default.
- W2156860669 hasConcept C203014093 @default.
- W2156860669 hasConcept C2522874641 @default.
- W2156860669 hasConcept C2775940106 @default.
- W2156860669 hasConcept C2777382497 @default.
- W2156860669 hasConcept C2777410769 @default.
- W2156860669 hasConcept C2777869810 @default.
- W2156860669 hasConcept C2778375690 @default.
- W2156860669 hasConcept C2779517838 @default.
- W2156860669 hasConcept C2779609443 @default.
- W2156860669 hasConcept C2780593183 @default.
- W2156860669 hasConcept C2911091166 @default.
- W2156860669 hasConcept C71924100 @default.
- W2156860669 hasConcept C90924648 @default.
- W2156860669 hasConceptScore W2156860669C126322002 @default.
- W2156860669 hasConceptScore W2156860669C197934379 @default.
- W2156860669 hasConceptScore W2156860669C203014093 @default.
- W2156860669 hasConceptScore W2156860669C2522874641 @default.
- W2156860669 hasConceptScore W2156860669C2775940106 @default.
- W2156860669 hasConceptScore W2156860669C2777382497 @default.
- W2156860669 hasConceptScore W2156860669C2777410769 @default.
- W2156860669 hasConceptScore W2156860669C2777869810 @default.
- W2156860669 hasConceptScore W2156860669C2778375690 @default.
- W2156860669 hasConceptScore W2156860669C2779517838 @default.
- W2156860669 hasConceptScore W2156860669C2779609443 @default.
- W2156860669 hasConceptScore W2156860669C2780593183 @default.
- W2156860669 hasConceptScore W2156860669C2911091166 @default.
- W2156860669 hasConceptScore W2156860669C71924100 @default.
- W2156860669 hasConceptScore W2156860669C90924648 @default.
- W2156860669 hasIssue "6" @default.
- W2156860669 hasLocation W21568606691 @default.
- W2156860669 hasLocation W21568606692 @default.
- W2156860669 hasOpenAccess W2156860669 @default.
- W2156860669 hasPrimaryLocation W21568606691 @default.
- W2156860669 hasRelatedWork W1983206060 @default.
- W2156860669 hasRelatedWork W2076187113 @default.